GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Beneish M-Score

Remed Co (XKRX:302550) Beneish M-Score : -1.38 (As of Apr. 17, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Remed Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.38 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Remed Co's Beneish M-Score or its related term are showing as below:

XKRX:302550' s Beneish M-Score Range Over the Past 10 Years
Min: -2.96   Med: -2.42   Max: -0.53
Current: -1.38

During the past 8 years, the highest Beneish M-Score of Remed Co was -0.53. The lowest was -2.96. And the median was -2.42.


Remed Co Beneish M-Score Historical Data

The historical data trend for Remed Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Beneish M-Score Chart

Remed Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial -2.83 -0.53 -2.96 -2.42 -1.38

Remed Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.42 -2.67 -2.61 -2.37 -1.38

Competitive Comparison of Remed Co's Beneish M-Score

For the Medical Devices subindustry, Remed Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remed Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remed Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Remed Co's Beneish M-Score falls into.


;
;

Remed Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Remed Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.382+0.528 * 0.8786+0.404 * 0.7228+0.892 * 1.3786+0.115 * 0.741
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7141+4.679 * 0.10036-0.327 * 0.7063
=-1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was ₩8,273 Mil.
Revenue was 6446.227 + 6034.357 + 7757.188 + 5316.279 = ₩25,554 Mil.
Gross Profit was 3768.388 + 3376.309 + 4195.894 + 2833.273 = ₩14,174 Mil.
Total Current Assets was ₩28,652 Mil.
Total Assets was ₩59,063 Mil.
Property, Plant and Equipment(Net PPE) was ₩22,583 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,278 Mil.
Selling, General, & Admin. Expense(SGA) was ₩7,831 Mil.
Total Current Liabilities was ₩9,037 Mil.
Long-Term Debt & Capital Lease Obligation was ₩5,363 Mil.
Net Income was 2540.856 + 3644.012 + 1070.139 + -82.929 = ₩7,172 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -4262.576 + 3579.262 + 1682.5 + 245.338 = ₩1,245 Mil.
Total Receivables was ₩4,342 Mil.
Revenue was 4315.204 + 4167.142 + 4921.571 + 5132.218 = ₩18,536 Mil.
Gross Profit was 2059.18 + 1989.428 + 2186.784 + 2797.649 = ₩9,033 Mil.
Total Current Assets was ₩21,869 Mil.
Total Assets was ₩55,060 Mil.
Property, Plant and Equipment(Net PPE) was ₩23,095 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩955 Mil.
Selling, General, & Admin. Expense(SGA) was ₩7,954 Mil.
Total Current Liabilities was ₩16,678 Mil.
Long-Term Debt & Capital Lease Obligation was ₩2,329 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(8273.363 / 25554.051) / (4342.345 / 18536.135)
=0.323759 / 0.234264
=1.382

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9033.041 / 18536.135) / (14173.864 / 25554.051)
=0.487321 / 0.554662
=0.8786

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (28652.423 + 22582.61) / 59062.954) / (1 - (21869.418 + 23095.452) / 55060.329)
=0.132535 / 0.183353
=0.7228

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=25554.051 / 18536.135
=1.3786

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(954.513 / (954.513 + 23095.452)) / (1278.036 / (1278.036 + 22582.61))
=0.039689 / 0.053563
=0.741

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7830.588 / 25554.051) / (7954.485 / 18536.135)
=0.306432 / 0.429134
=0.7141

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5362.576 + 9037.335) / 59062.954) / ((2329.022 + 16678.237) / 55060.329)
=0.243806 / 0.345208
=0.7063

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(7172.078 - 0 - 1244.524) / 59062.954
=0.10036

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Remed Co has a M-score of -1.38 signals that the company is likely to be a manipulator.


Remed Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Remed Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Remed Co Business Description

Traded in Other Exchanges
N/A
Address
187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025
Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co Headlines

No Headlines